United States · FDA National Drug Code directory
Ranolazine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71205-867_278d3fa3-3304-43dc-8a2a-a463c8ae9e9d
- Product NDC
- 71205-867
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Ranolazine
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210824
- Source listing expiry
- 20261231
Source-listed ingredients
- RANOLAZINE — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-867-00) · 71205-867-00
- 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-867-30) · 71205-867-30
- 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-867-55) · 71205-867-55
- 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-867-60) · 71205-867-60
- 120 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-867-72) · 71205-867-72
- 180 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-867-78) · 71205-867-78
- 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71205-867-90) · 71205-867-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →